Skip to main content
SpringerLink
Log in

Spastic Facial Muscle Disorders

  • Chapter
  • First Online:
Craniofacial Muscles

  • 1809 Accesses

Abstract

Facial muscles are a group of striated muscles that, among other things, control facial expression and are innervated by the facial nerve (CNVII). In contrast, the nearby eyelid retractor muscle and masticator muscles are innervated by the oculomotor (CNIII) and mandibular branch of trigeminal nerve (CNV), respectively.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Adams WH, Digre KB, Patel BC, Anderson RL, Warner JE, Katz BJ (2006) The evaluation of light sensitivity in benign essential blepharospasm. Am J Ophthalmol 142(1):82–87

    PubMed  Google Scholar 

  • Adler CH, Zimmerman RA, Savino PJ, Bernardi B, Bosley TM, Sergott RC (1992) Hemifacial spasm: evaluation by magnetic resonance imaging and magnetic resonance tomographic angiography. Ann Neurol 32(4):502–506

    PubMed  CAS  Google Scholar 

  • Ainsworth JR, Kraft SP (1995) Long-term changes in duration of relief with botulinum toxin treatment of essential blepharospasm and hemifacial spasm. Ophthalmology 102(12):2036–2040

    PubMed  CAS  Google Scholar 

  • Alappan N, Shyam Sundar A, Varghese ST (Spring 2008) Neuroleptic induced laryngo-pharyngeal dystonia. J Neuropsychiatry Clin Neurosci 20(2):241–242

    PubMed  Google Scholar 

  • Albanese A (2011) Terminology for preparations of botulinum neurotoxins: what a difference a name makes. JAMA 305(1):89–90

    PubMed  CAS  Google Scholar 

  • Alderson K, Holds JB, Anderson RL (1991) Botulinum-induced alteration of nerve-muscle interactions in the human orbicularis oculi following treatment for blepharospasm. Neurology 41(11):1800–1805

    PubMed  CAS  Google Scholar 

  • Alster TS, Lupton JR (2003) Botulinum toxin type B for dynamic glabellar rhytides refractory to botulinum toxin type A. Dermatol Surg 29(5):516–518

    PubMed  Google Scholar 

  • Anderson RL, Patel BC, Holds JB, Jordan DR (1998) Blepharospasm: past, present, and future. Ophthal Plast Reconstr Surg 14(5):305–317

    PubMed  CAS  Google Scholar 

  • Aramideh M (1996) Ongerboer de Visser BW, Holstege G, Majoie CB Speelman JD. Blepharospasm in association with a lower pontine lesion. Neurology 46(2):476–478

    PubMed  CAS  Google Scholar 

  • Aramideh M, Ongerboer de Visser BW, Brans JW, Koelman JH, Speelman JD (1995) Pretarsal application of botulinum toxin for treatment of blepharospasm. J Neurol Neurosurg Psychiatry 59(3):309–311

    PubMed  CAS  Google Scholar 

  • Armstrong MW, Mountain RE, Murray JA (1996) Treatment of facial synkinesis and facial asymmetry with botulinum toxin type A following facial nerve palsy. Clin Otolaryngol Allied Sci 21(1):15–20

    PubMed  CAS  Google Scholar 

  • Baker RS, Sun WS, Hasan SA et al (1997) Maladaptive neural compensatory mechanisms in Bell’s palsy-induced blepharospasm. Neurology 49(1):223–229

    PubMed  CAS  Google Scholar 

  • Banik R, Miller NR (2004) Chronic myokymia limited to the eyelid is a benign condition. J Neuroophthalmol 24(4):290–292

    PubMed  Google Scholar 

  • Baumann L, Black L (2003) Botulinum toxin type B (Myobloc). Dermatol Surg 29(5):496–500; discussion 500

    Google Scholar 

  • Bodker FS, Olson JJ, Putterman AM (1993) Acquired blepharoptosis secondary to essential blepharospasm. Ophthalmic Surg 24(8):546–550

    PubMed  CAS  Google Scholar 

  • Borodic GE, Ferrante R (1992) Effects of repeated botulinum toxin injections on orbicularis oculi muscle. J Clin Neuroophthalmol 12(2):121–127

    PubMed  CAS  Google Scholar 

  • Borodic G, Johnson E, Goodnough M, Schantz E (1996) Botulinum toxin therapy, immunologic resistance, and problems with available materials. Neurology 46(1):26–29

    PubMed  CAS  Google Scholar 

  • Boroojerdi B, Ferbert A, Schwarz M, Herath H, Noth J (1998) Botulinum toxin treatment of synkinesia and hyperlacrimation after facial palsy. J Neurol Neurosurg Psychiatry 65(1):111–114

    PubMed  CAS  Google Scholar 

  • Bradley EA, Hodge DO, Bartley GB (2003) Benign essential blepharospasm among residents of Olmsted County, Minnesota, 1976 to 1995: an epidemiologic study. Ophthal Plast Reconstr Surg 19(3):177–181

    PubMed  Google Scholar 

  • Brin MF, Blitzer A (1993) Botulinum toxin: dangerous terminology errors. J R Soc Med 86(8):493–494

    PubMed  CAS  Google Scholar 

  • Brin MF, Blitzer A, Stewart C (1998) Laryngeal dystonia (spasmodic dysphonia): observations of 901 patients and treatment with botulinum toxin. Adv Neurol 78:237–252

    PubMed  CAS  Google Scholar 

  • Castelbuono A, Miller NR (1998) Spontaneous remission in patients with essential blepharospasm and Meige syndrome. Am J Ophthalmol 126(3):432–435

    PubMed  CAS  Google Scholar 

  • Cather JC, Menter A (2002) Update on botulinum toxin for facial aesthetics. Dermatol Clin 20(4):749–761

    PubMed  CAS  Google Scholar 

  • Cavenar JO Jr, Brantley IJ, Braasch E (1978) Blepharospasm: organic or functional? Psychosomatics 19(10):623–628

    PubMed  Google Scholar 

  • Chen RS, Lu CS, Tsai CH (1996) Botulinum toxin A injection in the treatment of hemifacial spasm. Acta Neurol Scand 94(3):207–211

    PubMed  CAS  Google Scholar 

  • Choi WH, Song CW, Kim YB et al (2007) Skeletal muscle atrophy induced by intramuscular repeated dose of botulinum toxin type A in rats. Drug Chem Toxicol 30(3):217–227

    PubMed  CAS  Google Scholar 

  • Christiansen SP, Becker BA, Iaizzo PA, McLoon LK (2003) Extraocular muscle force generation after ricin-mAb35 injection: implications for strabismus treatment. J AAPOS 7(1):1–6

    PubMed  Google Scholar 

  • Daniele Ranoux CG (2007) Practical handbook on botulinum toxin. Solal Editeurs, Marseille

    Google Scholar 

  • Defazio G, Livrea P (2002) Epidemiology of primary blepharospasm. Mov Disord 17(1):7–12

    PubMed  Google Scholar 

  • Defazio G, Livrea P, Guanti G, Lepore V, Ferrari E (1993) Genetic contribution to idiopathic adult-onset blepharospasm and cranial-cervical dystonia. Eur Neurol 33(5):345–350

    PubMed  CAS  Google Scholar 

  • Defazio G, Livrea P, De Salvia R et al (2001) Prevalence of primary blepharospasm in a community of Puglia region, Southern Italy. Neurology 56(11):1579–1581

    PubMed  CAS  Google Scholar 

  • Defazio G, Abbruzzese G, Girlanda P et al (2002) Botulinum toxin A treatment for primary hemifacial spasm: a 10-year multicenter study. Arch Neurol 59(3):418–420

    PubMed  Google Scholar 

  • Defazio G, Brancati F, Valente EM et al (2003) Familial blepharospasm is inherited as an autosomal dominant trait and relates to a novel unassigned gene. Mov Disord 18(2):207–212

    PubMed  Google Scholar 

  • Defazio G, Martino D, Aniello MS et al (2006) A family study on primary blepharospasm. J Neurol Neurosurg Psychiatry 77(2):252–254

    PubMed  CAS  Google Scholar 

  • Diamond EL, Trobe JD, Belar CD (1984) Psychological aspects of essential blepharospasm. J Nerv Ment Dis 172(12):749–756

    PubMed  CAS  Google Scholar 

  • Dressler D (2000) Complete secondary botulinum toxin therapy failure in blepharospasm. J Neurol 247(10):809–810

    PubMed  CAS  Google Scholar 

  • Dressler D (2002) Clinical features of antibody-induced complete secondary failure of botulinum toxin therapy. Eur Neurol 48(1):26–29

    PubMed  CAS  Google Scholar 

  • Dressler D (2009) Routine use of Xeomin in patients previously treated with Botox: long term results. Eur J Neurol 16(Suppl 2):2–5

    PubMed  Google Scholar 

  • Dressler D (2010) Botulinum toxin for treatment of dystonia. Eur J Neurol 17(Suppl 1):88–96

    PubMed  Google Scholar 

  • Dressler D, Benecke R (2007) Pharmacology of therapeutic botulinum toxin preparations. Disabil Rehabil 29(23):1761–1768

    PubMed  Google Scholar 

  • Dressler D, Mander GJ (2008) Flink, K Equivalent potency of Xeomin® and Botox®. Mov Disord 23(suppl 1):S20–S21

    Google Scholar 

  • Dutton JJ, Buckley EG (1988) Long-term results and complications of botulinum A toxin in the treatment of blepharospasm. Ophthalmology 95(11):1529–1534

    PubMed  CAS  Google Scholar 

  • Dutton JJ, Fowler AM (2007) Botulinum toxin in ophthalmology. Surv Ophthalmol 52(1):13–31

    PubMed  Google Scholar 

  • Dystonia fact sheet. http://www.ninds.nih.gov/disorders/dystonias/detail_dystonias.htm

  • Elston JS (1986) Botulinum toxin treatment of hemifacial spasm. J Neurol Neurosurg Psychiatry 49(7):827–829

    PubMed  CAS  Google Scholar 

  • Elston JS (1987) Long-term results of treatment of idiopathic blepharospasm with botulinum toxin injections. Br J Ophthalmol 71(9):664–668

    PubMed  CAS  Google Scholar 

  • Elston JS (1992) The management of blepharospasm and hemifacial spasm. J Neurol 239(1):5–8

    PubMed  CAS  Google Scholar 

  • Engstrom PF, Arnoult JB, Mazow ML et al (1987) Effectiveness of botulinum toxin therapy for essential blepharospasm. Ophthalmology 94(8):971–975

    PubMed  CAS  Google Scholar 

  • Evidente VG, Adler CH (1998) Hemifacial spasm and other craniofacial movement disorders. Mayo Clin Proc 73(1):67–71

    PubMed  CAS  Google Scholar 

  • Fante RG, Frueh BR (2001) Differential section of the seventh nerve as a tertiary procedure for the treatment of benign essential blepharospasm. Ophthal Plast Reconstr Surg 17(4):276–280

    PubMed  CAS  Google Scholar 

  • Fine PG, Digre KB (1995) A controlled trial of regional sympatholysis in the treatment of photo-oculodynia syndrome. J Neuroophthalmol 15(2):90–94

    PubMed  CAS  Google Scholar 

  • Forget R, Tozlovanu V, Iancu A, Boghen D (2002) Botulinum toxin improves lid opening delays in blepharospasm-associated apraxia of lid opening. Neurology 58(12):1843–1846

    PubMed  CAS  Google Scholar 

  • Frevert J (2009) Xeomin is free from complexing proteins. Toxicon 54(5):697–701

    PubMed  CAS  Google Scholar 

  • Frueh BR, Felt DP, Wojno TH, Musch DC (1984) Treatment of blepharospasm with botulinum toxin. A preliminary report. Arch Ophthalmol 102(10):1464–1468

    PubMed  CAS  Google Scholar 

  • Frueh BR, Nelson CC, Kapustiak JF, Musch DC (1988) The effect of omitting botulinum toxin from the lower eyelid in blepharospasm treatment. Am J Ophthalmol 106(1):45–47

    PubMed  CAS  Google Scholar 

  • Frueh BR, Musch DC, Bersani TA (1992) Effects of eyelid protractor excision for the treatment of benign essential blepharospasm. Am J Ophthalmol 113(6):681–686

    PubMed  CAS  Google Scholar 

  • Garland PE, Patrinely JR, Anderson RL (1987) Hemifacial spasm. Results of unilateral myectomy. Ophthalmology 94(3):288–294

    PubMed  CAS  Google Scholar 

  • Gillum WN, Anderson RL (1981) Blepharospasm surgery. An anatomical approach. Arch Ophthalmol 99(6):1056–1062

    PubMed  CAS  Google Scholar 

  • Golbe LI, Davis PH, Lepore FE (1989) Eyelid movement abnormalities in progressive supranuclear palsy. Mov Disord 4(4):297–302

    PubMed  CAS  Google Scholar 

  • Gordon NS (2005) Focal dystonia, with special reference to writer’s cramp. Int J Clin Pract 59(9):1088–1090

    PubMed  CAS  Google Scholar 

  • Grandas F, Elston J, Quinn N, Marsden CD (1988) Blepharospasm: a review of 264 patients. J Neurol Neurosurg Psychiatry 51(6):767–772

    PubMed  CAS  Google Scholar 

  • Grandas F, Quinn N, Elston J, Marsden CD (1990) The cause of blepharospasm is unknown in most cases. Mov Disord 5(1):89

    PubMed  CAS  Google Scholar 

  • Greene P, Fahn S, Diamond B (1994) Development of resistance to botulinum toxin type A in patients with torticollis. Mov Disord 9(2):213–217

    PubMed  CAS  Google Scholar 

  • Hallett M (2002) Blepharospasm: recent advances. Neurology 59(9):1306–1312

    PubMed  Google Scholar 

  • Hambleton P (1992) Clostridium botulinum toxins: a general review of involvement in disease, structure, mode of action and preparation for clinical use. J Neurol 239(1):16–20

    PubMed  CAS  Google Scholar 

  • Harrison AR (2003) Chemodenervation for facial dystonias and wrinkles. Curr Opin Ophthalmol 14(5):241–245

    PubMed  Google Scholar 

  • Harrison AR, Berbos Z, Zaldivar RA, Anderson BC, Semmer M, Lee MS, McLoon LK (2011) Modulating neuromuscular junction density changes in botulinum toxin treated orbicularis oculi. Invest Ophthalmol Vis Sci 52:982–986

    PubMed  CAS  Google Scholar 

  • Hasan SA, Baker RS, Sun WS et al (1997) The role of blink adaptation in the pathophysiology of benign essential blepharospasm. Arch Ophthalmol 115(5):631–636

    PubMed  CAS  Google Scholar 

  • Hasegawa K, Watanabe T, Suzuki T et al (2007) A novel subunit structure of Clostridium botulinum serotype D toxin complex with three extended arms. J Biol Chem 282(34):24777–24783

    PubMed  CAS  Google Scholar 

  • Herrero MT, Barcia C, Navarro JM (2002) Functional anatomy of thalamus and basal ganglia. Childs Nerv Syst 18(8):386–404

    PubMed  Google Scholar 

  • Herz NL, Yen MT (2005) Modulation of sensory photophobia in essential blepharospasm with chromatic lenses. Ophthalmology 112(12):2208–2211

    PubMed  Google Scholar 

  • Hexsel D, Dal’forno T (2003) Type A botulinum toxin in the upper aspect of the face. Clin Dermatol 21(6):488–497

    PubMed  Google Scholar 

  • Ho SL, Cheng PW, Wong WC et al (1999) A case-controlled MRI/MRA study of neurovascular contact in hemifacial spasm. Neurology 53(9):2132–2139

    PubMed  CAS  Google Scholar 

  • Holds JB, Alderson K, Fogg SG, Anderson RL (1990) Motor nerve sprouting in human orbicularis muscle after botulinum A injection. Invest Ophthalmol Vis Sci 31(5):964–967

    PubMed  CAS  Google Scholar 

  • Horn AK, Porter JD, Evinger C (1993) Botulinum toxin paralysis of the orbicularis oculi muscle. Types and time course of alterations in muscle structure, physiology and lid kinematics. Exp Brain Res 96(1):39–53

    PubMed  CAS  Google Scholar 

  • Hotson JR, Boman DR (1991) Memory-contingent saccades and the substantia nigra postulate for essential blepharospasm. Brain 114(Pt 1A):295–307

    PubMed  Google Scholar 

  • Hott JS, Dalakas MC, Sung C, Hallett M, Youle RJ (1998) Skeletal muscle-specific immunotoxin for the treatment of focal muscle spasm. Neurology 50(2):485–491

    PubMed  CAS  Google Scholar 

  • Huang W, Foster JA, Rogachefsky AS (2000) Pharmacology of botulinum toxin. J Am Acad Dermatol 43(2 Pt 1):249–259

    PubMed  CAS  Google Scholar 

  • Ishikawa M, Ohira T, Namiki J et al (1997) Electrophysiological investigation of hemifacial spasm after microvascular decompression: F waves of the facial muscles, blink reflexes, and abnormal muscle responses. J Neurosurg 86(4):654–661

    PubMed  CAS  Google Scholar 

  • Jacobs L, Kaba S, Pullicino P (1994) The lesion causing continuous facial myokymia in multiple sclerosis. Arch Neurol 51(11):1115–1119

    PubMed  CAS  Google Scholar 

  • Jankovic JJ (1985) Clinical features, differential diagnosis, and pathogenesis of blepharospasm and cranial-cervical dystonia. In: Bosniak S (ed) Advances in ophthalmic plastic and reconstructive surgery, vol 4. Elsevier Science, Amsterdam, pp 67–82

    Google Scholar 

  • Jankovic J (1992) Diagnosis and classification of tics and Tourette syndrome. Adv Neurol 58:7–14

    PubMed  CAS  Google Scholar 

  • Jankovic J (2001) Tourette’s syndrome. N Engl J Med 345(16):1184–1192

    PubMed  CAS  Google Scholar 

  • Jankovic J (2009) Clinical efficacy and tolerability of Xeomin in the treatment of blepharospasm. Eur J Neurol 16(Suppl 2):14–18

    PubMed  Google Scholar 

  • Jankovic J, Orman J (1987) Botulinum A toxin for cranial-cervical dystonia: a double-blind, placebo-controlled study. Neurology 37(4):616–623

    PubMed  CAS  Google Scholar 

  • Jankovic J, Patten BM (1987) Blepharospasm and autoimmune diseases. Mov Disord 2(3):159–163

    PubMed  CAS  Google Scholar 

  • Jankovic J, Schwartz KS (1993) Longitudinal experience with botulinum toxin injections for treatment of blepharospasm and cervical dystonia. Neurology 43(4):834–836

    PubMed  CAS  Google Scholar 

  • Jankovic J, Stone L (1991) Dystonic tics in patients with Tourette’s syndrome. Mov Disord 6(3):248–252

    PubMed  CAS  Google Scholar 

  • Jankovic J, Havins WE, Wilkins RB (1982) Blinking and blepharospasm. Mechanism, diagnosis, and management. JAMA 248(23):3160–3164

    PubMed  CAS  Google Scholar 

  • Jankovic J, Vuong KD, Ahsan J (2003) Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia. Neurology 60(7):1186–1188

    PubMed  CAS  Google Scholar 

  • Jannetta PJ (1983) Hemifacial spasm: treatment by posterior fossa surgery. J Neurol Neurosurg Psychiatry 46(5):465–466

    PubMed  CAS  Google Scholar 

  • Jannetta PJ, Abbasy M, Maroon JC, Ramos FM, Albin MS (1977) Etiology and definitive microsurgical treatment of hemifacial spasm. Operative techniques and results in 47 patients. J Neurosurg 47(3):321–328

    PubMed  CAS  Google Scholar 

  • Jedynak CP, Palfi S, Vidailhet M, Kullmann B (1993) Hemifacial spasm treated with botulinum toxin. Rev Neurol 149(3):202–206

    PubMed  CAS  Google Scholar 

  • Jordan DR, Anderson RL, Digre KB (1990) Apraxia of lid opening in blepharospasm. Ophthalmic Surg 21(5):331–334

    PubMed  CAS  Google Scholar 

  • Jost WH, Blumel J, Grafe S (2007) Botulinum neurotoxin type A free of complexing proteins (XEOMIN) in focal dystonia. Drugs 67(5):669–683

    PubMed  CAS  Google Scholar 

  • Kahn L, Jordaan H (2001) The swallowing and voicing characteristics of pharyngeal dystonia: a single case report. S Afr J Commun Disord 48:21–31

    PubMed  CAS  Google Scholar 

  • Kalkanis SN, Eskandar EN, Carter BS, Barker FG, II (2003) Microvascular decompression surgery in the United States, 1996 to 2000: mortality rates, morbidity rates, and the effects of hospital and surgeon volumes. Neurosurgery 52(6):1251–1261; discussion 1261–1262

    Google Scholar 

  • Kalra HK, Magoon EH (1990) Side effects of the use of botulinum toxin for treatment of benign essential blepharospasm and hemifacial spasm. Ophthalmic Surg 21(5):335–338

    PubMed  CAS  Google Scholar 

  • Kemp LW, Reich SG (2004) Hemifacial Spasm. Curr Treat Options Neurol 6(3):175–179

    PubMed  Google Scholar 

  • Kennedy RH, Bartley GB, Flanagan JC, Waller RR (1989) Treatment of blepharospasm with botulinum toxin. Mayo Clin Proc 64(9):1085–1090

    PubMed  CAS  Google Scholar 

  • Krack P, Marion MH (1994) “Apraxia of lid opening,” a focal eyelid dystonia: clinical study of 32 patients. Mov Disord 9(6):610–615

    PubMed  CAS  Google Scholar 

  • Kraft SP, Lang AE (1988) Botulinum toxin injections in the treatment of blepharospasm, hemifacial spasm, and eyelid fasciculations. Can J Neurol Sci 15(3):276–280

    PubMed  CAS  Google Scholar 

  • Kulisevsky J, Marti MJ, Ferrer I, Tolosa E (1988) Meige syndrome: neuropathology of a case. Mov Disord 3(2):170–175

    PubMed  CAS  Google Scholar 

  • Lepore V, Defazio G, Acquistapace D et al (1995) Botulinum A toxin for the so-called apraxia of lid opening. Mov Disord 10(4):525–526

    PubMed  CAS  Google Scholar 

  • Levin H, Reddy R (2000) Clozapine in the treatment of neuroleptic-induced blepharospasm: a report of 4 cases. J Clin Psychiatry 61(2):140–143

    PubMed  CAS  Google Scholar 

  • Linder JS, Edmonson BC, Laquis SJ, Drewry RD Jr, Fleming JC (2002) Skin cooling before periocular botulinum toxin A injection. Ophthal Plast Reconstr Surg 18(6):441–442

    PubMed  Google Scholar 

  • Marti-Fabregas J, Montero J, Lopez-Villegas D, Quer M (1997) Post-irradiation neuromyotonia in bilateral facial and trigeminal nerve distribution. Neurology 48(4):1107–1109

    PubMed  CAS  Google Scholar 

  • Mauriello JA Jr, Dhillon S, Leone T, Pakeman B, Mostafavi R, Yepez MC (1996) Treatment selections of 239 patients with blepharospasm and Meige syndrome over 11 years. Br J Ophthalmol 80(12):1073–1076

    PubMed  Google Scholar 

  • Mauriello JA Jr, Carbonaro P, Dhillon S, Leone T, Franklin M (1998) Drug-associated facial dyskinesias–a study of 238 patients. J Neuroophthalmol 18(2):153–157

    PubMed  Google Scholar 

  • Mauriello JA Jr, Keswani R, Franklin M (1999) Long-term enhancement of botulinum toxin injections by upper-eyelid surgery in 14 patients with facial dyskinesias. Arch Otolaryngol Head Neck Surg 125(6):627–631

    PubMed  Google Scholar 

  • McCann JD, Gauthier M, Morschbacher R et al (1999) A novel mechanism for benign essential blepharospasm. Ophthal Plast Reconstr Surg 15(6):384–389

    PubMed  CAS  Google Scholar 

  • McCord CD Jr (1984) Coles WH, Shore JW, Spector R, Putnam JR. Treatment of essential blepharospasm. I. Comparison of facial nerve avulsion and eyebrow-eyelid muscle stripping procedure. Arch Ophthalmol 102(2):266–268

    PubMed  Google Scholar 

  • McLoon LK, Wirtschafter JD (2001) Doxil-induced chemomyectomy: effectiveness for permanent removal of orbicularis oculi muscle in monkey eyelid. Invest Ophthalmol Vis Sci 42(6):1254–1257

    PubMed  CAS  Google Scholar 

  • Nerad JA, Carter KD, Alford MA (2008) Oculoplastic and reconstructive surgery. Mosby Elsevier, Phliladelphia

    Google Scholar 

  • Nishikiori N, Ohba M, Osanai H (2005) Correlation of low-T3 syndrome with blepharospasm and hemifacial spasm. Jpn J Ophthalmol 49(4):328–330

    PubMed  Google Scholar 

  • Odergren T, Hjaltason H, Kaakkola S et al (1998) A double blind, randomised, parallel group study to investigate the dose equivalence of Dysport and Botox in the treatment of cervical dystonia. J Neurol Neurosurg Psychiatry 64(1):6–12

    PubMed  CAS  Google Scholar 

  • Osako M, Keltner JL (1991) Botulinum A toxin (Oculinum) in ophthalmology. Surv Ophthalmol 36(1):28–46

    PubMed  CAS  Google Scholar 

  • Pane A, Burdon M, Miller NR (2007) The neuro-ophthalmolgy survival guide. Mosby Elsevier, St Louis

    Google Scholar 

  • Park YC, Lim JK, Lee DK, Yi SD (1993) Botulinum a toxin treatment of hemifacial spasm and blepharospasm. J Korean Med Sci 8(5):334–340

    PubMed  CAS  Google Scholar 

  • Park J, Lee MS, Harrison AR (2011) Profile of Xeomin(R) (incobotulinumtoxinA) for the treatment of blepharospasm. Clin Ophthalmol 5:725–732

    PubMed  CAS  Google Scholar 

  • Patel BC, Anderson RL (1995) Blepharospasm and related facial movement disorders. Curr Opin Ophthalmol 6(5):86–99

    PubMed  CAS  Google Scholar 

  • Perman KI, Baylis HI, Rosenbaum AL, Kirschen DG (1986) The use of botulinum toxin in the medical management of benign essential blepharospasm. Ophthalmology 93(1):1–3

    PubMed  CAS  Google Scholar 

  • Price J, O’Day J (1994) Efficacy and side effects of botulinum toxin treatment for blepharospasm and hemifacial spasm. Aust N Z J Ophthalmol 22(4):255–260

    PubMed  CAS  Google Scholar 

  • Price J, Farish S, Taylor H, O’Day J (1997) Blepharospasm and hemifacial spasm. Randomized trial to determine the most appropriate location for botulinum toxin injections. Ophthalmology 104(5):865–868

    PubMed  CAS  Google Scholar 

  • Putterman AM (1990) Botulinum toxin injections in the treatment of seventh nerve misdirection. Am J Ophthalmol 110(2):205–206

    PubMed  CAS  Google Scholar 

  • Rahman EA, Trobe JD, Gebarski SS (2002) Hemifacial spasm caused by vertebral artery dolichoectasia. Am J Ophthalmol 133(6):854–856

    PubMed  Google Scholar 

  • Ranoux D, Gury C, Fondarai J, Mas JL, Zuber M (2002) Respective potencies of Botox and Dysport: a double blind, randomised, crossover study in cervical dystonia. J Neurol Neurosurg Psychiatry 72(4):459–462

    PubMed  CAS  Google Scholar 

  • Schantz EJ, Johnson EA (1990) Dose standardisation of botulinum toxin. Lancet 335(8686):421

    PubMed  CAS  Google Scholar 

  • Schicatano EJ, Basso MA, Evinger C (1997) Animal model explains the origins of the cranial dystonia benign essential blepharospasm. J Neurophysiol 77(5):2842–2846

    PubMed  CAS  Google Scholar 

  • Scott AB, Kennedy RA, Stubbs HA (1985) Botulinum A toxin injection as a treatment for blepharospasm. Arch Ophthalmol 103(3):347–350

    PubMed  CAS  Google Scholar 

  • Shorr N, Seiff SR, Kopelman J (1985) The use of botulinum toxin in blepharospasm. Am J Ophthalmol 99(5):542–546

    PubMed  CAS  Google Scholar 

  • Siatkowski RM, Tyutyunikov A, Biglan AW et al (1993) Serum antibody production to botulinum A toxin. Ophthalmology 100(12):1861–1866

    PubMed  CAS  Google Scholar 

  • Soulayrol S, Caperan A, Penot-Ragon C, Beaulieu JP, Gastaut JL (1993) Treatments by local injections of botulinum toxin in neurology. Indications and results. Presse Med 22(20):957–963

    PubMed  CAS  Google Scholar 

  • Soylev MF, Kocak N, Kuvaki B, Ozkan SB, Kir E (2002) Anesthesia with EMLA cream for botulinum A toxin injection into eyelids. Ophthalmologica 216(5):355–358

    PubMed  Google Scholar 

  • Tarsy D (2000) Tardive Dyskinesia. Curr Treat Options Neurol 2(3):205–214

    PubMed  Google Scholar 

  • Tolosa E, Compta Y (2006) Dystonia in Parkinson’s disease. J Neurol 253(Suppl 7):VII7–VII13

    PubMed  Google Scholar 

  • Tozlovanu V, Forget R, Iancu A, Boghen D (2001) Prolonged orbicularis oculi activity: a major factor in apraxia of lid opening. Neurology 57(6):1013–1018

    PubMed  CAS  Google Scholar 

  • Vissenberg I, Dieleman-Smet H, Tassignon MJ (1993) Botulinum A toxin therapy in ophthalmology: a report of patients with facial dystonias. Bull Soc Belge Ophtalmol 248:77–82

    PubMed  CAS  Google Scholar 

  • Wenzel T, Schnider P, Griengl H, Birner P, Nepp J, Auff E (2000) Psychiatric disorders in patients with blepharospasm—a reactive pattern? J Psychosom Res 48(6):589–591

    PubMed  CAS  Google Scholar 

  • Wirtschafter JD (1991) Clinical doxorubicin chemomyectomy. An experimental treatment for benign essential blepharospasm and hemifacial spasm. Ophthalmology 98(3):357–366

    PubMed  CAS  Google Scholar 

  • Wirtschafter JD (1994) Chemomyectomy of the orbicularis oculi muscles for the treatment of localized hemifacial spasm. J Neuroophthalmol 14(4):199–204

    PubMed  CAS  Google Scholar 

  • Wirtschafter JD, McLoon LK (1998) Long-term efficacy of local doxorubicin chemomyectomy in patients with blepharospasm and hemifacial spasm. Ophthalmology 105(2):342–346

    PubMed  CAS  Google Scholar 

  • Wutthiphan S, Kowal L, O’Day J, Jones S, Price J (1997) Diplopia following subcutaneous injections of botulinum A toxin for facial spasms. J Pediatr Ophthalmol Strabismus 34(4):229–234

    PubMed  CAS  Google Scholar 

  • Zwirner P, Dressler D, Kruse E (1997) Spasmodic laryngeal dyspnea: a rare manifestation of laryngeal dystonia. Eur Arch Otorhinolaryngol 254(5):242–245

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology, University of Minnesota, Minneapolis, MN, USA

    Juwan Park M.D.

  2. Department of Ophthalmology, University of Minnesota, 420 Delaware Street SE, Minneapolis, MN, 55455, USA

    Andrew R. Harrison M.D. & Michael S. Lee M.D.

Authors
  1. Juwan Park M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andrew R. Harrison M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michael S. Lee M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrew R. Harrison M.D. .

Editor information

Editors and Affiliations

  1. Dept. Ophthalmology, University of Minnesota, Minneapolis, 55455, Minnesota, USA

    Linda K. McLoon

  2. Dept. Physiology, University of Kentucky, Leader Ave. 138, Lexington, 40506-9983, Kentucky, USA

    Francisco Andrade

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media New York

About this chapter

Cite this chapter

Park, J., Harrison, A.R., Lee, M.S. (2012). Spastic Facial Muscle Disorders. In: McLoon, L., Andrade, F. (eds) Craniofacial Muscles. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-4466-4_16

Download citation

Publish with us

Policies and ethics

Search

Navigation